Morepen in generics pact with US companyIllustrative image – not actual.

Morepen Laboratories Ltd has tied up with Florida-based Drugmax Inc to manufacture and market generic drug formulations in the US.

 

Morepen would have a 51 per cent stake in the new yet-to-be-named joint venture. The company plans to start manufacture and marketing of loratadine, as it goes off patent in 2002. Morepen is the second largest manufacturer of loratadine in the world, after Schering Plough. Morepen plans to move on to other generic formulations for the US markets, at a later stage.

 

Drugmax has distribution centres all over the US.

← All latest storiesBack to top →